NeuroDerm Ltd. Ordinary Shares
NDRM
NDRM was delisted on the 17th of October, 2017.
50 hedge funds and large institutions have $134M invested in NeuroDerm Ltd. Ordinary Shares in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 10 closing their positions.
58% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 12
10% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 10
2% more funds holding
Funds holding: 49 → 50 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $150M → $134M (-$15.7M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1.14M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Scopia Capital Management
New York
|
+$8.57M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$4.72M |
| 3 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$2.58M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.25M |
| 5 |
B
Bailard
Foster City,
California
|
+$1.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$5.52M |
| 2 |
GC
GMT Capital
Atlanta,
Georgia
|
-$3.23M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.62M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$1.36M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$755K |
NDRM Hedge Fund Activity: Q1 2016 in Review
50 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q1 2016, worth a combined $134M — down 10% from $150M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new NDRM positions and 10 closed out — a net gain of 1 holder — while 19 added to existing stakes and 12 trimmed.
The largest buyer was Scopia Capital Management, adding an estimated $8.57M. The largest seller was Redmile Group, cutting an estimated $5.52M.
- 50 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q1 2016, up from 49 in Q4 2015.
- Funds reported $134M of NeuroDerm Ltd. Ordinary Shares stock for Q1 2016, down 10% quarter-over-quarter.
- 11 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q1 2016 and 10 closed out, a net change of +1 holder.
- The largest NeuroDerm Ltd. Ordinary Shares buyer in Q1 2016 was Scopia Capital Management, an estimated $8.57M added.
- The largest NeuroDerm Ltd. Ordinary Shares seller in Q1 2016 was Redmile Group, an estimated $5.52M sold.
Based on aggregated 13F filings for Q1 2016.